PR gaffe? Goldman Sachs receives H1N1 vaccine
This week, BusinessWeek reported that about 13 of New York’s largest employers — including Goldman Sachs and Citigroup — received doses of the H1N1 vaccine that the companies had ordered. The article states that these companies received small doses for “high risk employees,” and the city’s health office said these companies did not receive preferential treatment. “It’s not that they received it over someone else, it’s that they placed an order … This i…
Become a Ragan Insider member to read this article and all other archived content.
Sign up today
Already a member? Log in here.
Learn more about Ragan Insider.